MIT Technology Review Asks Who Gets Credit When AI Designs a Drug
MIT Technology Review·medium signal
MIT Technology Review published an August 21 piece anchored on Insilico Medicine's claim that its computer models discovered a pulmonary fibrosis candidate, examining how much of the attribution holds up. The question is not academic: credit assignment drives patent claims, publication authorship and funding allocation across AI-for-biotech. It is the same attribution fight now surfacing in chemistry, materials and mathematics.